Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA okays MTI's (Micro Therapeutics) Onyx brain aneurysm trial:

This article was originally published in Clinica

Executive Summary

The US FDA has given Micro Therapeutics (MTI) the go-ahead to begin a 138-patient pivotal trial of its Onyx liquid embolic system for the treatment of brain aneurysms. The product, which is already CE-marked for sale in Europe (see Clinica no 934, p 17), will be tested in 15 US sites. The Irvine, California company says it expects to file a PMA application with the FDA in the second half of 2002.

Topics

UsernamePublicRestriction

Register

MT070706

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel